Aimco Pesticides (AIMCOPEST) Q2 FY27' Q2 Loss Deepens Despite 76% Sequential Revenue Jump
The agrochemical firm's sales recovered from a weak Q1, but a severe cost surge pushed the net loss to ₹4.63 crore, highlighting persistent profitability challenges.
Aimco Pesticides reported a 76% sequential revenue jump in Q2 FY27, but costs more than doubled, leading to a ₹4.63 crore loss. The company faces weak demand, rising inventory, and a complete absence of institutional investors.
For Aimco Pesticides, a quarter that brought a much-needed sales rebound ended with a deeper hole in the bottom line. Revenue jumped 76% from a seasonally weak June quarter, but costs surged even faster, turning a marginal profit into a significant loss.
The numbers tell a story of recovery without reward. Consolidated revenue reached ₹38.58 crore, though it remained 15% below last year's September quarter. The net loss widened to ₹4.63 crore, a sharp reversal from the ₹0.61 crore profit in Q1. This pushed the net profit margin to -12%, its worst in five quarters.
Revenue & profit
Revenue (₹ Cr)
Profit (₹ Cr)
Net Profit Margin (%)
| Metric | CurrentQ2 FY27 (Sep 2026) | PreviousQ1 FY27 (Jun 2026) |
|---|---|---|
| Revenue (₹ Cr) | 38.58 | 21.97 |
| Profit (₹ Cr) | -4.63 | 0.61 |
| Net Profit Margin (%) | -12.0 | 2.8 |
Why the rebound didn't help
The revenue recovery was overshadowed by a 105% quarter-on-quarter jump in total expenses. A report by MarketsMojo notes the operating profit, excluding other income, plunged to a loss of ₹3.86 crore. This indicates the cost of goods sold exceeded gross revenues, a sign of either aggressive discounting or inefficient production.
Weak global agrochemical demand is a key headwind. A Jefferies report cited by Chinimandi notes that despite rising crop prices, demand remained subdued amid a weak monsoon. This aligns with Aimco's 15% yearly revenue drop and rising inventory, which scanx.trade reports increased to ₹56.25 crore by September end.
The financial strain ahead
With a current ratio of 0.96, the company's short-term liabilities exceed its assets. The debt-to-equity ratio stands at 0.85, and the interest cover is negative. Notably, institutional investors have completely exited. A MarketsMojo analysis shows zero FII or mutual fund holdings, reflecting a lack of confidence in a near-term turnaround.
Management has not provided explicit forward guidance. Past commentary, cited by StockFin.ai, indicated a strategic pivot toward profitability over top-line growth, with capex contingent on customer commitments. The immediate challenge is converting stocked inventory into cash without further eroding margins.
Key Points
- Revenue recovered 76% sequentially from a low base, but remained below the year-ago level by 15%.
- Total expenses more than doubled QoQ, causing a severe margin squeeze and a net loss of ₹4.63 crore.
- Working capital pressure is evident with rising inventory and receivables, while institutional investor holdings are nil.
- The company's recovery hinges on improving demand absorption and cost control in a weak agrochemical market.
Hexa Perspective
This quarter underscores Aimco Pesticides' operational fragility. A revenue bounce is meaningless if it comes at the cost of a negative gross margin. The path to stability requires not just sales growth, but sales at a price that covers costs—a tall order in a soft demand environment. Investors are weighing whether this is a cyclical trough or a structural decline. The absence of institutional interest and the consistent net losses over the trailing twelve months suggest the burden of proof lies firmly with the company. The next few quarters must show that the top-line recovery can be sustained without destroying the bottom line.
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.
